Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Affymax, Inc. (OTCQB: AFFY) announced today that its Board of Directors has adopted a Tax Benefit Preservation Plan, or Rights Plan, in an effort to preserve the value of its significant net...
Affymax, Inc. (OTCQB: AFFY) today announced that its Board of Directors has declared a special cash distribution to shareholders in the amount of $0.05 per share. The special cash...
Xstelos Announces Intention To Vote Against Affymax's Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders PR Newswire NEW YORK, Sept. 19, 2014 NEW YORK, Sept. 19, 2014...
TO: ALL PERSONS AND ENTITIES THAT PURCHASED AFFYMAX, INC., (“AFFYMAX”) COMMON STOCK DURING THE PERIOD FROM AUGUST 8, 2012 THROUGH FEBRUARY 22, 2013, BOTH DATES INCLUSIVE (THE “CLASS...
Affymax, Inc. (OTCQB:AFFY) today reported financial results for the second quarter ending June 30, 2014. The net income for the second quarter of 2014 was $7.2 million (or $0.19 per share...
Affymax, Inc. (AFFY), a biopharmaceutical company, today announced that its Board of Directors has approved the liquidation and dissolution of the company, subject to stockholder approval...
OTC Daily Trading Focus List: Axxess Pharma, Inc. Petvivo Holdings, Inc. Integrated Cannabis Solutions, Inc. BreedIT Corp, Affymax, Inc. PR Newswire LONDON, June 18, 2014 LONDON, June 18, 2014...
Takeda will withdraw the Omontys U.S. New Drug Application (NDA) Affymax, Inc. and Takeda Pharmaceutical Company Limited (Takeda) Osaka, Japan (June 16, 2014) announced today that their...
As previously announced, on May 28, 2013, Affymax, Inc. (the “Company”) received a determination letter (the “Determination Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) delisting the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0008 | 0.0008 | 0.0008 | 3363 | 0.0008 | CS |
| 4 | 0 | 0 | 0.0008 | 0.0012 | 0.0008 | 55485 | 0.00087829 | CS |
| 12 | 0.0001 | 14.2857142857 | 0.0007 | 0.0024 | 0.0007 | 22916 | 0.00087315 | CS |
| 26 | 0.0001 | 14.2857142857 | 0.0007 | 0.0024 | 0.0007 | 12760 | 0.00085566 | CS |
| 52 | 0.0002 | 33.3333333333 | 0.0006 | 0.0407 | 0.0006 | 14768 | 0.00086945 | CS |
| 156 | -0.0052 | -86.6666666667 | 0.006 | 0.0407 | 0.0002 | 13283 | 0.00569638 | CS |
| 260 | -0.0327 | -97.6119402985 | 0.0335 | 0.26 | 0.0002 | 47268 | 0.08263942 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
